Clinical trial
Efficacy of Macrolide Immunomodulation in Severe Sepsis
NCT00708799 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Macrolide Immunomodulation in Severe Sepsis
- Lead sponsor
- VA Office of Research and Development
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2007
- Completion date
- November 30, 2013
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.